---
category: listing
circular_id: a48f1230d2a287eb
date: '2025-12-08'
description: Neochem Bio Solutions Limited's equity shares to be listed on NSE EMERGE
  SME Platform effective December 09, 2025, trading under symbol NEOCHEM in Trade
  for Trade Surveillance Segment.
draft: false
guid: https://nsearchives.nseindia.com/content/circulars/CML71693.zip
impact: low
impact_ranking: low
importance_ranking: medium
justification: Standard SME IPO listing notification with limited market-wide impact,
  relevant primarily to investors interested in the specific company and SME segment
  traders.
pdf_url: https://nsearchives.nseindia.com/content/circulars/CML71693.zip
processing:
  attempts: 1
  content_hash: a2c2086276c3e4f9
  processed_at: '2025-12-08T15:51:25.351055'
  processor_version: '2.0'
  stage: completed
  status: published
published_date: '2025-12-08T00:00:00+05:30'
rss_url: https://nsearchives.nseindia.com/content/circulars/CML71693.zip
severity: medium
source: nse
stocks:
- NEOCHEM
tags:
- emerge-platform
- listing
- sme
- surveillance
- trade-for-trade
title: Listing of Equity Shares of Neochem Bio Solutions Limited (SME IPO)
---

## Summary

The National Stock Exchange has announced the listing of equity shares of Neochem Bio Solutions Limited on the EMERGE SME Platform effective December 09, 2025. The company will trade under the symbol 'NEOCHEM' with ISIN INE21UM01018. Initially, shares will trade in Series 'ST' (Trade for Trade Surveillance Segment with Settlement Type 'W') before transitioning to Series 'SM' (Normal Rolling Segment). The IPO consists of 17,120,753 equity shares of Rs. 10/- face value at an issue price of Rs. 98/- per share.

## Key Points

- **Symbol**: NEOCHEM
- **ISIN**: INE21UM01018
- **Face Value**: Rs. 10/-
- **Issue Price**: Rs. 98/- per share
- **Total Securities**: 17,120,753 equity shares
- **Market Lot**: 1,200 equity shares
- **Trading Series**: ST (Trade for Trade Surveillance Segment - TFTS with Settlement Type 'W')
- **Market Maker**: Rikhav Securities Limited
- **Maximum Permissible Spread**: Within 10%
- **Registrar & Transfer Agent**: MUFG Intime India Private Limited (formerly Link Intime India Private Limited)

## Regulatory Changes

No regulatory changes introduced. This circular follows existing SEBI regulations:
- SEBI circular no. CIR/MRD/DP/01/2012 & CIR/MRD/DP/02/2012 dated January 20, 2012 regarding pre-open session for IPO category
- Exchange Circular No. NSE/CMTR/37202 dated March 14, 2018 regarding continuous market trading

## Compliance Requirements

- Trading members must identify the security by its designated code (NEOCHEM)
- Trading must be conducted in specified lot size of 1,200 equity shares
- Security will participate in pre-open session for IPO and other category scrips
- Security will be available for trading in continuous market
- Lock-in provisions apply as per Annexure I (specific lock-in details provided for different shareholding blocks)

## Important Dates

- **Circular Date**: December 08, 2025
- **Effective Date**: December 09, 2025
- **Financial Year**: April 2025 - March 2026

## Impact Assessment

**Market Impact**: Limited to SME segment participants and investors interested in the chemical/bio-solutions sector. The Trade for Trade surveillance mechanism indicates enhanced monitoring initially.

**Operational Impact**: 
- Market makers and traders dealing in SME securities need to update their systems for the new listing
- The mandatory lot size of 1,200 shares requires higher minimum investment compared to main board stocks
- Initial listing in surveillance segment (Series ST) may restrict certain trading activities

**Company Details**:
- **Registered Office**: 303, W1, Opp. Vikramnagar Colony, Off. Iscon Ambli Road, Daskroi, Ahmedabad â€“ 380058, Gujarat
- **Compliance Officer**: Ms. Shradha Sarthak Agarwal
- **Contact**: +91 079 35217792, compliance@neochem.in
- **Website**: www.neochem.in

**Trading Characteristics**: The placement in Trade for Trade segment with 'W' settlement type indicates stricter surveillance measures, requiring compulsory delivery-based trading without intraday squared-off positions allowed initially.